Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
- 1
How stripping diversity, equity and inclusion from health care may make Americans sicker - 25 High Limit Outer Hard Drives For Information Stockpiling
- 3Gauging the Upsides and downsides of Visas: A Complete Aide
- 4Peruvian ex-President Martin Vizcarra sentenced to 14 years in prison
- 5Japan deploys the military to counter a surge in bear attacks
- 10 times the sky amazed us in 2025
- Netflix's 'Lord of the Flies' show blends 'Adolescence' and 'Yellowjackets'
- Getting Your Youngsters' Future: Grasping Legacy Regulations
- Which restaurants and fast food chains will be open on Christmas Eve and Christmas Day?
- The Significance of Prenuptial Arrangements in Separation Procedures
- An Artemis 2 astronaut took a 'bath' on camera on the way to the moon. Mission Control's reaction was priceless (video)
- Ice Spice's 'Big Guy' SpongeBob song is stuck in everyone's heads again — and TikTok is fueling it
- The Best 20 Photography Instagram Records to Follow
- Artemis II astronauts arrive in Florida to prepare for launch to the moon
